Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- NA
Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC
- Status
- RECRUITING
- Phase
- PHASE3
A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery
- Status
- RECRUITING
- Phase
- PHASE3
Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation
- Status
- RECRUITING
- Phase
- PHASE3
A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- NA
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
AK112 in Non-squamous Non-small Cell Lung Cancer (NSCLC)Patients With Actionable Genomic Alterations (AGA) Who Have Failed to Previous Tyrosine Kinase Inhibitor (TKI) Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
DK222 Study at Hopkins
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3